1032823-75-8
1032823-75-8
Chemical Structure
GSK1292263
- CAS No.: 1032823-75-8
- Formula:C23H28N4O4S
- Molecular Weight:456.56
IUPAC Name: 3-isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
InChIKey: AYJRTVVIBJSSKN-UHFFFAOYSA-N
SMILES: CC(C1=NOC(N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)S(C)(=O)=O)=N1)C
Biological Activity: GSK-1292263 is an orally available GPR119 agonist with pEC50s of 6.9 and 6.7 for human and rat GPR119, respectively. GSK-1292263 can be used for the research of type 2 diabetes mellitus (T2DM)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK1292263 | 98.68% | GSK-1292263 is an orally available GPR119 agonist with pEC50s of 6.9 and 6.7 for human and rat GPR119, respectively. GSK-1292263 can be used for the research of type 2 diabetes mellitus (T2DM). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
GSK1292263 (Standard) | ≥98% | GSK1292263 (Standard) is the analytical standard of GSK1292263. This product is intended for research and analytical applications. GSK-1292263 is an orally available GPR119 agonist with pEC50s of 6.9 and 6.7 for human and rat GPR119, respectively. GSK-1292263 can be used for the research of type 2 diabetes mellitus (T2DM). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
